164 related articles for article (PubMed ID: 37870753)
1. Anti-cancer targets and molecular mechanisms of formononetin in treating osteosarcoma based on network pharmacology.
Chen L; Zhou Y; Weng Z; Liu S; Li T; Wang Y; Yang Y; Liu H; Huang W
Aging (Albany NY); 2023 Oct; 15(20):11489-11507. PubMed ID: 37870753
[TBL] [Abstract][Full Text] [Related]
2. Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells.
Di Fiore R; Marcatti M; Drago-Ferrante R; D'Anneo A; Giuliano M; Carlisi D; De Blasio A; Querques F; Pastore L; Tesoriere G; Vento R
Bone; 2014 Mar; 60():198-212. PubMed ID: 24373920
[TBL] [Abstract][Full Text] [Related]
3. Formononetin induces apoptosis of human osteosarcoma cell line U2OS by regulating the expression of Bcl-2, Bax and MiR-375 in vitro and in vivo.
Hu W; Xiao Z
Cell Physiol Biochem; 2015; 37(3):933-9. PubMed ID: 26381132
[TBL] [Abstract][Full Text] [Related]
4. The proapoptotic effect of formononetin in human osteosarcoma cells: involvement of inactivation of ERK and Akt pathways.
Liu Y; He J; Chen X; Li J; Shen M; Yu W; Yang Y; Xiao Z
Cell Physiol Biochem; 2014; 34(3):637-45. PubMed ID: 25170541
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis induced by chamaejasmine in human osteosarcoma cells through p53 pathway.
Yang D; Wang P; Ren X
Tumour Biol; 2015 Jul; 36(7):5433-9. PubMed ID: 25677904
[TBL] [Abstract][Full Text] [Related]
6. Astragalus polysaccharides decrease proliferation, migration, and invasion but increase apoptosis of human osteosarcoma cells by up-regulation of microRNA-133a.
Chu Y; Fang Y; Chi J; Li J; Zhang D; Zou Y; Wang Z
Braz J Med Biol Res; 2018 Nov; 51(12):e7665. PubMed ID: 30462772
[TBL] [Abstract][Full Text] [Related]
7. [p14ARF enhances cisplatin-induced apoptosis in human osteosarcoma cells in p53-independent pathway].
Huang X; Yuan X; Chen Z; Liang S
Zhonghua Yi Xue Za Zhi; 2015 Sep; 95(35):2875-9. PubMed ID: 26815194
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑22 inhibits the proliferation and migration, and increases the cisplatin sensitivity, of osteosarcoma cells.
Zhou X; Natino D; Zhai X; Gao Z; He X
Mol Med Rep; 2018 May; 17(5):7209-7217. PubMed ID: 29568877
[TBL] [Abstract][Full Text] [Related]
9. Melatonin Increases the Sensitivity of Osteosarcoma Cells to Chemotherapy Drug Cisplatin.
Hosseini F; Shanehbandi D; Soleimanpour J; Yousefi B; Alemi F
Drug Res (Stuttg); 2022 Jul; 72(6):312-318. PubMed ID: 35636434
[TBL] [Abstract][Full Text] [Related]
10. Clinical case report of patients with osteosarcoma and anticancer benefit of calycosin against human osteosarcoma cells.
Qiu R; Ma G; Li X; Shi Q; Li X; Zhou X; Tang Y; Xie Z; Liao S; Qin Y; Wang R; Ye Y; Luo J; Zhang J
J Cell Biochem; 2019 Jun; 120(6):10697-10706. PubMed ID: 30652346
[TBL] [Abstract][Full Text] [Related]
11. Cinobufagin Induces Apoptosis in Osteosarcoma Cells Via the Mitochondria-Mediated Apoptotic Pathway.
Dai G; Zheng D; Guo W; Yang J; Cheng AY
Cell Physiol Biochem; 2018; 46(3):1134-1147. PubMed ID: 29669353
[TBL] [Abstract][Full Text] [Related]
12. [Selective inducement effect of bacterial redox protein azurin on apoptosis of human osteosarcoma cell line U2OS].
Ye ZM; Miao XD; Yang DS; Xu RZ; Huang X; Ge FF
Ai Zheng; 2005 Mar; 24(3):298-304. PubMed ID: 15757530
[TBL] [Abstract][Full Text] [Related]
13. 15,16-dihydrotanshinone I Induces Apoptosis and Inhibits the Proliferation, Migration of Human Osteosarcoma Cell Line 143B in vitro.
Chen X; Li Q; He Y; Du H; Zhan Z; Zhao H; Shi J; Ye Q; Hu J
Anticancer Agents Med Chem; 2017; 17(9):1234-1242. PubMed ID: 26478521
[TBL] [Abstract][Full Text] [Related]
14. Capsaicin induces apoptosis in human osteosarcoma cells through AMPK-dependent and AMPK-independent signaling pathways.
Ying H; Wang Z; Zhang Y; Yang TY; Ding ZH; Liu SY; Shao J; Liu Y; Fan XB
Mol Cell Biochem; 2013 Dec; 384(1-2):229-37. PubMed ID: 24005536
[TBL] [Abstract][Full Text] [Related]
15. STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma.
Oi T; Asanuma K; Matsumine A; Matsubara T; Nakamura T; Iino T; Asanuma Y; Goto M; Okuno K; Kakimoto T; Yada Y; Sudo A
Int J Oncol; 2016 Dec; 49(6):2275-2284. PubMed ID: 27840900
[TBL] [Abstract][Full Text] [Related]
16. Anti-cancer targets of formononetin and molecular mechanisms in osteosarcoma: Findings of bioinformatic and experimental assays.
Hu W; Wu X; Tang J; Zhao G; Xiao N; Zhang L; Li S
J Cell Mol Med; 2019 May; 23(5):3505-3511. PubMed ID: 30873755
[TBL] [Abstract][Full Text] [Related]
17. Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells.
Roepke M; Diestel A; Bajbouj K; Walluscheck D; Schonfeld P; Roessner A; Schneider-Stock R; Gali-Muhtasib H
Cancer Biol Ther; 2007 Feb; 6(2):160-9. PubMed ID: 17218778
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA‑22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma.
Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Sun L; Sun C; Feng W; Guo SB
Mol Med Rep; 2020 Nov; 22(5):3911-3921. PubMed ID: 33000186
[TBL] [Abstract][Full Text] [Related]
19. Induction of G2/M phase cell cycle arrest and apoptosis by ginsenoside Rf in human osteosarcoma MG‑63 cells through the mitochondrial pathway.
Shangguan WJ; Li H; Zhang YH
Oncol Rep; 2014 Jan; 31(1):305-13. PubMed ID: 24173574
[TBL] [Abstract][Full Text] [Related]
20. Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway.
Jin W; Zhou L; Yan B; Yan L; Liu F; Tong P; Yu W; Dong X; Xie L; Zhang J; Xu Y; Li C; Yuan Q; Shan L; Efferth T
J Cell Mol Med; 2018 Sep; 22(9):4423-4436. PubMed ID: 29993186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
